Strimvelis® for Treating Severe Combined Immunodeficiency Caused by Adenosine Deaminase Deficiency: An Evidence Review Group Perspective of a NICE Highly Specialised Technology Evaluation
PharmacoEconomics - Open - Switzerland
doi 10.1007/s41669-018-0102-3
Full Text
Open PDFAbstract
Available in full text
Date
October 17, 2018
Authors
Publisher
Springer Science and Business Media LLC